We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Shoots Down FTC’s Request to Reconsider AbbVie, Teva Pay-For-Delay Dismissal
Judge Shoots Down FTC’s Request to Reconsider AbbVie, Teva Pay-For-Delay Dismissal
A federal judge Wednesday said AbbVie and Teva can continue an arrangement that delays the launch of generic versions of the testosterone drug Androgel — rejecting the FTC’s request that he reconsider his earlier decision that the agreement was not pay-for-delay.